* In this study, we will determine the effect of olanzapine on the expression of TCF7L2 and SLC30A8.
* The relationship of the polymorphism of TCF7L2 and SLC30A8 with antipsychotic-induced metabolic syndrome in schizophrenia patients.
Age
18–45
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Clinical diagnosis of first episode schizophrenia
Must be able to swallow tablets
Take only one antipsychotics
You may not be if
liver or renal or cardiovascular diseases
pregnant or lactating women
drug and alcohol dependence
Clareo Health | The Mechanism of TCF7L2 and SLC30A8 on Antipsychotic-induced Metabolic Syndrome
